Back to funds
View filing
Saturn V Capital Management LP
Updated 6 days agoManaged by Saturn V Capital Management Lp • Latest filing Q3 2026
Portfolio value
$683.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $544.9M |
| Q1 2026 | $552.2M |
| Q2 2026 | $697.5M |
| Q3 2026 | $683.1M |
Top holdings
24 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $130.1M | 4.47M | 19.05% | — | |
| 2 | $52.4M | 529.3K | 7.67% | — | |
| 3 | ? N/A IMMIX BIOPHARMA INC | $48.5M | 4.66M | 7.10% | — |
| 4 | $44.2M | 1.39M | 6.47% | — | |
| 5 | $43.9M | 772.3K | 6.43% | — | |
| 6 | $40.9M | 513.8K | 5.98% | — | |
| 7 | $40.1M | 612.7K | 5.87% | — | |
| 8 | $36.3M | 3.48M | 5.31% | — | |
| 9 | $34.8M | 150.3K | 5.10% | — | |
| 10 | $24.9M | 312.4K | 3.64% | — | |
| 11 | $22.8M | 2.04M | 3.34% | — | |
| 12 | $22.5M | 1.57M | 3.30% | — | |
| 13 | ? N/A X4 PHARMACEUTICALS INC | $21.4M | 7.37M | 3.13% | — |
| 14 | $21.1M | 2.86M | 3.09% | — | |
| 15 | $19.8M | 2.00M | 2.90% | — | |
| 16 | $13.5M | 837.2K | 1.97% | — | |
| 17 | $13.2M | 518.1K | 1.94% | — | |
| 18 | $11.4M | 758.8K | 1.67% | — | |
| 19 | $8.5M | 2.03M | 1.24% | — | |
| 20 | $8M | 3.87M | 1.16% | — |